|Study marks the emergence of disease-modifying treatments for autism spectrum disorders|
|December 16, 2010|
|Boston, Mass. -- Researchers at Children's Hospital Boston have begun a randomized, placebo-controlled trial to test a potential drug treatment for Rett syndrome, the leading known genetic cause of autism in girls. The drug, mecasermin, a synthetic form of insulin-like growth factor-1 (IGF-1), is already FDA-approved for children with short stature due to IGF-1 deficiency.|
Run4Rett 2017 - Thanks to everyone who came out to support Team Abby at the Run4Rett last month! We had a fabulous day with the warmest, sunniest weather ever. Abby had be...
2 days ago